Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-28 @ 12:48 PM
Study NCT ID:
NCT01150292
Status:
COMPLETED
Last Update Posted:
2019-05-28
First Post:
2010-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients
Sponsor:
Hospices Civils de Lyon
Organization:
Study Overview
Official Title:
Intake of Low Dose of Docosahexaenoic Acid: Effects on Platelet Functions and Redox Status in Diabetic Patients
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim: to determine the effects of DHA supplementation:
* on the platelet function through their aggregation and the pathway of arachidonic acid metabolism
* on redox status on cells and plasma
* on inflammation in 16 type 2 diabetic patients in a cross-over study comparing DHA (400 mg/day for 2 weeks) vs Sunflower oil (placebo). Each period is separated by a wash-out period of 6 to 9 weeks.
* on the platelet function through their aggregation and the pathway of arachidonic acid metabolism
* on redox status on cells and plasma
* on inflammation in 16 type 2 diabetic patients in a cross-over study comparing DHA (400 mg/day for 2 weeks) vs Sunflower oil (placebo). Each period is separated by a wash-out period of 6 to 9 weeks.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: